scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0735-1097(02)02702-X |
P698 | PubMed publication ID | 12535806 |
P50 | author | Markus Perola | Q28050040 |
P2093 | author name string | Amir Snapir | |
Mika Scheinin | |||
Pekka J Karhunen | |||
Jussi Mikkelsson | |||
Antti Penttilä | |||
P2860 | cites work | alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans | Q33836786 |
Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization | Q33923585 | ||
Experimental rupture of atherosclerotic lesions increases distal vascular resistance: a limiting factor to the success of infarct angioplasty | Q43852835 | ||
Circadian variation in ischemic threshold. A mechanism underlying the circadian variation in ischemic events | Q54266651 | ||
An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events | Q57303695 | ||
Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation | Q67521427 | ||
Sudden coronary death in the United States: 1980-1985 | Q69962135 | ||
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly | Q73254792 | ||
Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death | Q74403919 | ||
Genetic determinants of coronary vasomotor tone in humans | Q74514639 | ||
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries | Q77367245 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
risk factor | Q1475848 | ||
P304 | page(s) | 190-194 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death | |
P478 | volume | 41 |
Q37776088 | Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease |
Q37458988 | Arrhythmia pharmacogenomics: methodological considerations. |
Q37418554 | Common genetic variants in sudden cardiac death |
Q33955008 | Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. |
Q37930472 | Dexmedetomidine: applications for the pediatric patient with congenital heart disease |
Q99594675 | Distribution and relative expression of vasoactive receptors on arteries |
Q78818561 | Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background |
Q36102464 | Epidemiology and genetics of sudden cardiac death |
Q49359736 | Genetic variants in post myocardial infarction patients presenting with electrical storm of unstable ventricular tachycardia |
Q37117485 | Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise |
Q34530128 | Genetics of sudden death. |
Q33778116 | Genomics, heart failure and sudden cardiac death. |
Q28204423 | Identification of duplicated fourth alpha2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish |
Q34586312 | Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells |
Q36442044 | Insertion and deletion polymorphism in the alpha-2B adrenoceptor gene in pregnant women ripens gestational diabetes mellitus |
Q49093167 | Insertion/insertion genotype of α2B-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus |
Q39291350 | Lack of Association Between Adrenoreceptor Genotype and the Vasoconstriction Response to Dexmedetomidine |
Q41351582 | Lack of association between ADRA2B-4825 gene insertion/deletion polymorphism and migraine in Chinese Han population. |
Q51180489 | Lack of association between alpha2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation--preliminary report. |
Q38286038 | Pharmacogenetics of cardiac inotropy |
Q35911140 | Pharmacogenomics of adrenoceptors. |
Q37981274 | Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown |
Q41019601 | Predicting sudden cardiac death using common genetic risk variants for coronary artery disease |
Q83659593 | Reprint of: the paradox of α-adrenergic coronary vasoconstriction revisited |
Q38104209 | Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? |
Q30433543 | Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop |
Q24802084 | The insertion/deletion variation in the alpha2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes |
Q37860513 | The paradox of α-adrenergic coronary vasoconstriction revisited |
Q35622041 | Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology? |
Search more.